The Newshound

Patients who swap Wegovy weight-loss jabs for a daily pill kept shedding pounds, real-world study finds

From the Newshound archive · first published 30 September 2026 · last updated 1 October 2026.

Patients who swap Wegovy weight-loss jabs for a daily pill kept shedding pounds, real-world study finds

Novo Nordisk's Wegovy pill enabled patients to carry on losing weight after moving away from injections, with a real-world study recording an average body weight reduction of 4.1% in just three months. The findings were presented at the EASD 2026 diabetes conference and drew on data from patients already using weight-loss jabs before they made the switch. Researchers say the results indicate that the oral formulation is a workable alternative for people who are unwilling or unable to continue with injections.

One study found the pill matches the injection for effectiveness, a significant finding for the millions seeking a needle-free option.

Novo Nordisk published the data as pressure grows on drugmakers to provide more accessible obesity treatments beyond weekly injections.

Morecnbc.comPeople switching to Novo's Wegovy pill from obesity injections kept losing weight in real-world study - cnbc.comqz.comSwitching to Novo Nordisk's weight loss pill helped people keep shedding pounds - qz.comPR NewswirePeople switching from weight-loss injections to Novo's Wegovy® pill lost 4.1% body weight on average after three months, according to real-world data presented at EASD2026 - PR NewswireDaily MailWeight loss pill is just as effective as jab new study suggestsReutersPatients switching to Novo Nordisk's Wegovy pill from shots lose more weight in real-world study
Read today's full feed at The Newshound →